INCY
Incyte Corporation
Incyte Corporation is a biopharmaceutical company focused on oncology and inflammation, with its most significant political signal being $13.1M in annual payments to doctors and a direct equity holding by a former President.
Govt Dependence
2/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL
BusinessWhat INCY does
Incyte Corporation is a biopharmaceutical company that discovers, develops, and commercializes proprietary therapeutics, primarily in oncology and inflammation/autoimmunity. Its key revenue driver is the JAK inhibitor Jakafi (ruxolitinib) for myelofibrosis and polycythemia vera. The company also commercializes other oncology products and has a pipeline of clinical-stage candidates.
12 months past · 3 months futureINCY activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
240 trading days ·
3 congressional trades shown
·
0 insider buys
·
11 13F filings
·
3 past bill actions
·
16 upcoming markups
Executive Branch ConflictsINCY held by Trump-administration officials
1 cabinet/senior official reported INCY positions in OGE Form 278 disclosures across 2 filings.
Lifetime Government AwardsINCY federal contracts by year
$402K
total awarded · 2020–2024
18
contracts on file
2024
peak year ($159K)
Top contracts by award amount
$120K
Department of Veterans Affairs
2024-07-02
PEMIGATINIB
$64K
Department of Veterans Affairs
2021-01-19
PEMAZYRE 13.5
$25K
Department of Veterans Affairs
2022-04-27
PEMAZYRE
$13K
Department of Veterans Affairs
2024-01-12
PEMIGATINIB
$13K
Department of Veterans Affairs
2024-01-26
PEMIGATINIB PEMAZYRE
5 years · 18 contracts
Smart Money · 13F HoldingsHedge funds holding INCY
$2.76B
Total INCY held by tracked 13F funds
40
Funds with INCY positions
+40
Funds opened this quarter
Renaissance Technologies
$393M
opened
1 overlap
2025-12-31
Renaissance Technologies
$384M
opened
2025-09-30
Renaissance Technologies
$316M
opened
2024-06-30
Renaissance Technologies
$297M
opened
2024-09-30
Renaissance Technologies
$282M
opened
2024-12-31
Renaissance Technologies
$264M
opened
2025-06-30
Renaissance Technologies
$225M
opened
2025-03-31
D.E. Shaw & Co.
$65M
opened
2024-09-30
32 more 13F positions tracked · quarterly delta charts available in member dashboard
Politicians Trading INCYMembers of Congress with recent INCY positions
2 politicians traded INCY across 13 disclosed transactions totaling $104K (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just INCY). 0-30 LOW · 30-60 MID · 60+ HIGH.
Congressional TradesWho in Congress is trading INCY
2026-01-29
Ro Khanna
Purchase
$1,001 - $15,000
2025-05-19
Ro Khanna
Purchase
$1,001 - $15,000
2025-05-19
Ro Khanna
purchase
$1,001 - $15,000
2025-05-15
Robert P. Bresnahan
sale
$1,001 - $15,000
2025-05-15
Robert P. Bresnahan
Sale
$1,001 - $15,000
2025-02-19
Ro Khanna
sale
$1,001 - $15,000
2025-02-19
Ro Khanna
Sale
$1,001 - $15,000
2025-01-17
Ro Khanna
purchase
$1,001 - $15,000
2025-01-17
Ro Khanna
Purchase
$1,001 - $15,000
2024-11-15
Ro Khanna
purchase
$1,001 - $15,000
2024-11-15
Ro Khanna
Purchase
$1,001 - $15,000
2024-08-02
Ro Khanna
purchase
$1,001 - $15,000
30+ trades on file · most recent 2026-02-06
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting INCYLive legislation impacting this stock
S.827 · 119th
Supporting Rural Veterans Access to Healthcare Services Act
HR.1860 · 119th
Women Veterans Cancer Care Coordination Act
HR.2068 · 119th
Veterans Patient Advocacy Act
HR.2020 · 119th
New Mexico Rural Veteran Health Care Access Act
S.999 · 119th
Public Health Improvement Act
HR.2045 · 119th
Medicare Dental, Vision, and Hearing Benefit Act of 2025
HR.2062 · 119th
To amend the Internal Revenue Code of 1986 to treat membership in a health care sharing ministry as a medical expense, and for oth
HR.2048 · 119th
Metastatic Breast Cancer Access to Care Act
HR.2085 · 119th
Mental Health Research Accelerator Act of 2025
SJRES.36 · 119th
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted b
Political ProfileWhere INCY sits in Washington
[object Object]
STRUCTURAL: High regulatory density (85) from 8 pending healthcare bills and a major physician payment program ($13.1M in 2024). EVIDENTIARY: Direct equity holding by a former President (`get_executive_branch_exposure.by_ticker[0].holdings`) and repeated congressional purchases by Rep. Khanna. Net: Evidentiary bullish signals are offset by a lack of formal lobbying infrastructure and a congressional critic, resulting in a neutral net signal.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Heightened scrutiny of physician payment programs under the Sunshine ActCMS"`get_political_influence.doctor_payments` shows 77,681 payments totaling $13.1M in 2024, a high-volume program vulnerable to regulatory review."
Regulatory opportunities
-
Veterans Affairs formulary inclusion for oncology productsDepartment of Veterans Affairs"`get_government_precedent.federal_contracts_summary[0]` shows 18 contracts with the VA totaling $401.5K, establishing a procurement precedent."
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
Member intelligence layer
Live signals + predictions for INCY — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades INCY
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout INCY & political exposure
Does Incyte Corporation (INCY) hold federal contracts?
Yes. Incyte Corporation has 18 federal contract awards totaling $401,506, primarily from agencies including Department of Veterans Affairs. See full contract list and amounts on this page.
Which Trump cabinet officials own INCY stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in INCY on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
Has Congress traded INCY stock?
97 congressional trades by 6 unique members of Congress, most recently on 2026-01-29. See the Congressional Trading panel for politician-by-politician breakdown.
What is INCY political risk profile?
Government dependence: 2/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.
How does GovGreed track INCY political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. INCY data is updated daily from these official federal sources.